EP1191850A4 - Composition et traitement antalgique - Google Patents

Composition et traitement antalgique

Info

Publication number
EP1191850A4
EP1191850A4 EP00943174A EP00943174A EP1191850A4 EP 1191850 A4 EP1191850 A4 EP 1191850A4 EP 00943174 A EP00943174 A EP 00943174A EP 00943174 A EP00943174 A EP 00943174A EP 1191850 A4 EP1191850 A4 EP 1191850A4
Authority
EP
European Patent Office
Prior art keywords
oil
percent
pain relief
weight
relief composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00943174A
Other languages
German (de)
English (en)
Other versions
EP1191850A1 (fr
Inventor
Richard Weise
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SWISS MEDICA, INC.
Original Assignee
SWISS MEDICA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/522,581 external-priority patent/US6444238B1/en
Application filed by SWISS MEDICA Inc filed Critical SWISS MEDICA Inc
Publication of EP1191850A1 publication Critical patent/EP1191850A1/fr
Publication of EP1191850A4 publication Critical patent/EP1191850A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera

Definitions

  • the present invention relates generally to a composition for relieving pain and the use of the same for relieving pain. More particularly, the present invention relates to a composition that contains a mixture of essential oils and that is used for treating pain in a human body.
  • the present invention is a method of treating pain in a human body.
  • the method includes preparing a pain relief composition from a mixture of aloe vera oil, eucalyptus oil, lemon oil, orange oil, peppermint oil, and rosemary oil.
  • the method also includes topically applying the pain relief composition to the human body proximate to where a person is experiencing discomfort.
  • the present invention is a composition that relieves pain when applied topically to the human body proximate the location of the pain.
  • the pain relief composition of the present invention is particularly suited for relieving pain associated with PMS when the pain relief composition is applied to the person's abdomen.
  • the pain relief composition of the present invention is also useful in treating other physical ailments, such as muscle strains, muscle sprains, muscle aches, headaches, bruises, arthritis, and joint pain. Additionally, the pain relief composition reduces swelling when applied topically in areas of a body where swelling is found.
  • the pain relief composition of the present invention is formulated from organically derived essential oils. As such, the pain relief composition provides consumers with a technique to reduce the level of pain while not using artificial, man- made compositions.
  • the organically-derived nature of the composition of the present invention has substantial value to those individuals who desire to reduce pain without using artificial, man-made compositions.
  • the pain relief composition is substantially a mixture of essential oils.
  • Essential oils used in preparing the pain relief composition of the present invention include aloe vera, peppermint, lemon, orange, and rosemary oils.
  • the concentration of aloe vera oil is between about 10 and 18 percent by weight and preferably between about 13 and 16 percent by weight.
  • the concentration of eucalyptus oil is between about 0.5 and 5 percent by weight and preferably between about 1 and 3 percent by weight.
  • the concentration of lemon oil is between about 0.5 and 5.0 percent by weight and preferably about 1 and 3 percent by weight.
  • the concentration of orange oil is between about 0.5 and 5.0 percent by weight and preferably about 1 and 3 percent by weight.
  • the concentration of peppermint oil is between about 65 and 80 percent by weight and preferably between about 70 and 75 percent by weight.
  • the concentration of rosemary oil is between about 2 and 10 percent by weight and preferably about 4 and 7 percent by weight.
  • composition of the present invention also preferably includes calendula oil ⁇ Calendula officinalis), which is derived from the marigold plant.
  • the concentration of calendula oil is up to about 25 percent by weight and preferably about 20 percent by weight.
  • additional essential oils in the pain relief composition without departing from the scope of the present invention.
  • additional oil is camphor oil, which my be used at a concentration of up to 5 percent by weight.
  • tagette oil is another suitable essential oil.
  • Aloe vera oil is obtained from the dried leaves of Aloe barbadensis Miller ⁇ Aloe vera Linne).
  • Camphor oil contains bicyclo [2.2.1] heptan-2-one, 1,7,7-trimethyl-, 2- Camphanone; 2-Bornanone [76-22-2] C 10 H 15 O. Camphor oil is preferably obtains by steam distilling chips of the camphor tree and then purifying the material thereby obtained.
  • Eucalyptus oil contains not less than 70 percent by weight of C 10 H 18 O (eucalyptol). Other components typically found in eucalyptus oil include d-a-pinene, globulol, pinocarveol, pinocarvone, and selected aldehydes.
  • Eucalyptus oil has a specific gravity of between about 0.905 and 0.925 at 25°C. Eucalyptus oil is preferably obtained by distilling fresh leaves o ⁇ Eucalyptus globulus Labillardiere or other species o ⁇ Eucalyptus L'Heritier (Fam Myrtaceae).
  • Lemon oil typically contains citral, d-limonene, l- ⁇ pinene, ⁇ -pinene, camphene, ⁇ -phellandrene and y-terpinene.
  • the total aldehyde content of lemon oil, calculated as citral (C 10 H, 6 O), is between about 2.2 and 5.5 percent.
  • Lemon oil has a specific gravity of between about 0.849 and 0.855 at 25°C. Lemon oil is obtained by expression from the fresh peel of the fruit of Citrus limon (Linne) Burmann filius (Fam Rutaceae).
  • Orange oil consists of at least 90 percent by weight d-limonene along with other odorous constituents such as n-decylic aldehyde, citral, d-linalool, n-nonyl alcohol and traces of esters o ⁇ formic, acetic, caprylic and capric acids.
  • the total aldehyde content, calculated as decanal (C 10 H 20 O) is between about 1.2 and 2.5 percent.
  • Orange oil has a specific gravity of between about 0.842 and 0.846 at 25°C.
  • Orange oil is prepared by expression from the fresh peel of the ripe fruit of Citrus sinensis (Linne) Osbeck (Fam Rutaceae).
  • Peppermint oil contains not less than 5 percent of esters, calculated as menthyl acetate (C 12 H 22 O 2 ), and not less than 50 percent of total menthol (C 10 H 20 O), free and as esters.
  • Other components typically found in peppermint oil include methone,
  • Peppermint oil is distilled with steam from the fresh overground parts of the flowering plant of Mentha piperia Linne (Fam Labiatae). Peppermint oil has a specific gravity of between about 0.896 and 0.908 at 25°C.
  • Rosemary oil contains not less than 1.5 percent of esters calculated as bornyl acetate (C 12 H 20 O 2 ), and not less than 8 percent of total borneol (C 10 H 18 O), free and as esters. Cineol is present at a concentration of between 19 and 25 percent by weight. Terpenes d- and l- Q r-pinene, dipentene and camphene, and the ketone camphor also occur in rosemary oil. Rosemary oil is distilled with steam from the fresh flowering tops o ⁇ Rosemarinus officinalis Linn ⁇ (Fam Labiatae). Rosemary oil has a specific gravity of between about 0.894 and 0.912 at 25°C.
  • each of the components is put through a subjective quality control evaluation in which the color, smell and weight are evaluated. These results are then compared with previous samples of the same components to ensure that each of the essential oils of the same quality as the previously used components.
  • each of the components is separately filtered to remove any particulate matter contained therein. Filtering is preferably accomplished by passing the components through a Grade 2 filter. The components are then warmed to a temperature of between about 30 and
  • each of the components is at approximately the same temperature. Providing each of the components at approximately the same temperature when the components are mixed eliminates or significantly reduces undesirable interactions between the components.
  • the order in which the components are mixed is also believed to play an important role in preparing a stable composition.
  • the components are mixed together based on the hydrophil content.
  • the components with the highest hydrophil content are mixed together first followed by the components with the lower hydrophil content.
  • the hydrophil content of the essential oils used in producing the pain relief composition tend to vary based upon several factors including the location in which the plant that was used to produce the essential oil was grown. As such, the hydrophil content should be monitored with each group of materials.
  • the hydrophil content is preferably determined by evaluating each material in a gas chromatograph.
  • peppermint oil has the highest hydrophil content of about 40-45 percent.
  • the hydrophil content of rosemary oil is typically about 18.
  • the hydrophil content of eucalyptus oil is typically about 11 percent.
  • the mixture is sufficiently mixed so that the mixture is substantially homogeneous.
  • the temperature of the mixture is monitored to ensure the temperature of the mixture is still within a desired temperature range. If necessary, the mixture is heated to bring the temperature of the mixture with the desired range. The mixing process is repeated until all of the components have been mixed into the composition.
  • the pain relief composition of the present invention When used for treating the pain associated with menstrual cramps, the pain relief composition of the present invention is applied to the patient's abdomen about 3 to 4 times a day. An amount of the pain relief composition used is selected based on the desired application area so as to provide a relatively thin layer of the pain relief composition over the entire affected area.
  • a pain relief composition was prepared using the components and concentrations set forth in Table 1.
  • the components were subjectively evaluated for color, smell and weight. Each of these characteristics was found to be of a satisfactory level.
  • the components were then filtered through a Grade 2 filter. Next, the components were each heated to a temperature of between 35 and 38°C using a water bath.
  • the peppermint oil was found to have the highest hydrophil content and, as such, was the first component used in formulating the mixture.
  • the rosemary oil was mixed at the specified concentration with the peppermint oil to prepare a homogeneous mixture.
  • the process was then repeated separately mixing, in order, aloe, camphor, lemon and orange oils at the specified concentrations. After the addition of each component, the mixture was sufficiently mixed to prepare a substantially homogeneous mixture.
  • the pain relief composition was applied to the abdomen of a female who was experiencing a significant amount of discomfort associated with PMS. Within a short period of time after the pain relief composition was applied to the person's abdomen she noted a significant reduction of the discomfort associated with PMS. The reduced level of pain continued for more than 4 hours.
  • a pain relief composition was prepared using the components and concentrations set forth in Table 2.
  • the components were subjectively evaluated for color, smell and weight. Each of these characteristics was found to be of a satisfactory level.
  • the components were then filtered through a Grade 2 filter. Next, the components were each heated to a temperature of between 35 and 38°C using a water bath. Table 2
  • the peppermint oil was found to have the highest hydrophil content and, as such, was the first component used in formulating the mixture.
  • the rosemary oil was mixed at the specified concentration with the peppermint oil to prepare a homogeneous mixture.
  • the process was then repeated separately mixing, in order, aloe, camphor, lemon and orange oils at the specified concentrations. After the addition of each component, the mixture was sufficiently mixed to prepare a substantially homogeneous mixture.
  • the pain relief composition was applied to the abdomen of a female who was experiencing a significant amount of discomfort associated with PMS. Within a short period of time after the pain relief composition was applied to the person's abdomen she noted a significant reduction of the discomfort associated with PMS. The reduced level of pain continued for more than 4 hours.
  • a pain relief composition was prepared using the components and concentrations set forth in Table 3.
  • the components were subjectively evaluated for color, smell and weight. Each of these characteristics was found to be of a satisfactory level.
  • the components were then filtered through a Grade 2 filter. Next, the components were each heated to a temperature of between 35 and 38°C using a water bath.
  • the peppermint oil was found to have the highest hydrophil content and, as such, was the first component used in formulating the mixture.
  • the rosemary oil was mixed at the specified concentration with the peppermint oil to prepare a homogeneous mixture.
  • the process was then repeated separately mixing, in order, aloe, lemon, orange and calendula oils at the specified concentrations. After the addition of each component, the mixture was sufficiently mixed to prepare a substantially homogeneous mixture.
  • the pain relief composition was applied to the abdomen of a female who was experiencing a significant amount of discomfort associated with PMS. Within a short period of time after the pain relief composition was applied to the person's abdomen she noted a significant reduction of the discomfort associated with PMS. The reduced level of pain continued for more than 4 hours.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne une composition et un traitement antalgique destiné à l'être humain. A cet effet, on réalise une composition antalgique à base d'un mélange d'huiles essentielles d'aloès officinal, d'eucalyptus, de citron, d'orange, de menthe et de romarin. On utilise ensuite en application locale la composition antalgique au voisinage de la zone endolorie.
EP00943174A 1999-07-02 2000-06-21 Composition et traitement antalgique Withdrawn EP1191850A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14223399P 1999-07-02 1999-07-02
US142233P 1999-07-02
US522581 2000-03-10
US09/522,581 US6444238B1 (en) 2000-03-10 2000-03-10 Pain relief composition and method of relieving pain
PCT/US2000/017559 WO2001001782A1 (fr) 1999-07-02 2000-06-21 Composition et traitement antalgique

Publications (2)

Publication Number Publication Date
EP1191850A1 EP1191850A1 (fr) 2002-04-03
EP1191850A4 true EP1191850A4 (fr) 2006-07-26

Family

ID=26839892

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00943174A Withdrawn EP1191850A4 (fr) 1999-07-02 2000-06-21 Composition et traitement antalgique

Country Status (6)

Country Link
EP (1) EP1191850A4 (fr)
AU (1) AU5768300A (fr)
BR (1) BR0012140A (fr)
CA (1) CA2374035A1 (fr)
MX (1) MXPA02000362A (fr)
WO (1) WO2001001782A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4731036B2 (ja) * 2001-04-11 2011-07-20 高砂香料工業株式会社 殺ダニ用精油混合物、殺ダニ剤及び殺ダニスプレー
US7691419B2 (en) * 2007-12-20 2010-04-06 Dileva Rose Marie Compositions and methods for treating skin conditions in mammals
US20210220423A1 (en) * 2021-04-06 2021-07-22 Earl Marek Pain reliever composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073366A (en) * 1989-05-30 1991-12-17 Fred Beck Analgesic composition useful in providing a temporary relief from symptoms of arthritis
RU2127584C1 (ru) * 1996-02-29 1999-03-20 Коновалов Валерий Николаевич Мазь противовоспалительного, обезболивающего и ранозаживляющего действия (варианты)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2350103A1 (fr) * 1976-05-06 1977-12-02 Ohf Etudes Participations Produits actifs sur l'erytheme solaire
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073366A (en) * 1989-05-30 1991-12-17 Fred Beck Analgesic composition useful in providing a temporary relief from symptoms of arthritis
RU2127584C1 (ru) * 1996-02-29 1999-03-20 Коновалов Валерий Николаевич Мазь противовоспалительного, обезболивающего и ранозаживляющего действия (варианты)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199344, Derwent World Patents Index; Class B04, AN 1993-347316, XP002385285 *
See also references of WO0101782A1 *

Also Published As

Publication number Publication date
MXPA02000362A (es) 2004-05-21
CA2374035A1 (fr) 2001-01-11
BR0012140A (pt) 2002-04-30
AU5768300A (en) 2001-01-22
EP1191850A1 (fr) 2002-04-03
WO2001001782A1 (fr) 2001-01-11

Similar Documents

Publication Publication Date Title
US20070134195A1 (en) Topical Analgesic for Sensitive Skin
US6444238B1 (en) Pain relief composition and method of relieving pain
JPH07505133A (ja) 冷却加工し，黄色液汁及びアロインを除去したアロエ・ヴェラ抽出物を含有する皮膚治療用混合物
JP6412901B2 (ja) 組成物の製造方法
JPH0757734B2 (ja) 鎮静用香料組成物および香粧品
WO2021179567A1 (fr) Huile essentielle composite de feuilles d'armoise chinoise pour soulager les maux de gorge et son procédé de préparation
JPH0757733B2 (ja) 覚醒用香料組成物および香粧品
Edwards The Aromatherapy Companion: Medicinal Uses/Ayurvedic Healing/Body-Care Blends/Perfumes & Scents/Emotional Health & Well-Being
CN110403869A (zh) 一种植物舒缓复合精油及其制备方法
WO2002080879A2 (fr) Traitement pour la peau
CN106214571A (zh) 一种苦楝驱蚊虫组合物及其制备方法和应用
EP1191850A1 (fr) Composition et traitement antalgique
CN112891504A (zh) 一种以生姜药渣为基材的四季护肤防疫生姜膏及制备方法
EP0668768B1 (fr) Composition permettant de lutter contre les dermatomycoses et leurs agents causals, ainsi que contre la sudation et les odeurs corporelles
KR101084489B1 (ko) 두피 보호,개선용 화장료 조성물 및 그 제조방법.
CN113813319A (zh) 一种治疗蜂毒的药物及其制备方法
CN113332346A (zh) 一种纤体减肥精油及其制备方法
CN1660264A (zh) 一种浴足中药组合物及其制备方法
CN113332345A (zh) 安神养颜的中药组合物及其制备方法
CN112603860A (zh) 一种艾草舒敏修护面霜及其制备方法
CN111632006A (zh) 一种驱蚊喷雾及其制备方法
CN111171954A (zh) 一种复方精油
CN1094264A (zh) 烟剂保健品
DE4244754C2 (de) Bekämpfung der Erreger von Dermatomykosen in Bekleidungsstücken
CN1099879C (zh) 活血保健药酒

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020108

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SWISS MEDICA, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20060623

17Q First examination report despatched

Effective date: 20070730

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080212